5/5/2015

Marina Biotech Announces SMARTICLES®- mediated Delivery of a Double-stranded Oligonucleotide to Immune Cells

6/10/2015

Marina Biotech Expands European and Canadian Patent Protection of its SMARTICLES Nucleic Acid Delivery Technology

11/3/2015

Marina Biotech Reports that Licensee ProNAi Therapeutics Initiates ‘Brighton’ Phase II Trial of PNT2258 in Patients with Richter’s Transformation

Scroll Up